Dr. Serzan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-3466Fax+1 617-632-2165
Education & Training
- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2015 - 2018
- Rutgers Robert Wood Johnson Medical SchoolClass of 2015
Certifications & Licensure
- MA State Medical License 2022 - 2025
- DC State Medical License 2018 - 2022
- VA State Medical License 2019 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsClinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials.Neil J Shah, Alexandra Della Pia, Tianmin Wu, Aquino Williams, Melinda Weber
Cancers. 2024-06-14 - 2 citationsFirst-Line Treatment for Intermediate and Poor Risk Advanced or Metastatic Clear Cell Renal Cell Carcinoma.Michael T Serzan, Wenxin Xu, Stephanie A Berg
Hematology/oncology Clinics of North America. 2023-10-01 - 6 citationsThe impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study.Shaked Lev-Ari, Michael Serzan, Tianmin Wu, Andrew Ip, Lauren Pascual
Cancer. 2023-06-15
Press Mentions
- How Can Kidney Cancer Patients Benefit from New Combination Therapy?April 23rd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: